Literature DB >> 849636

Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis.

F C Luft, C E Grim, L R Willis, J T Higgins, M H Weinberger.   

Abstract

Previous studies have reported an exaggerated natriuresis in hypertensive man; however, a systematic appraisal of this response in various forms of hypertension has not been made. We measured fractional excretion of sodium (FENa) during a four hour intravenous infusion of 2 liters normal saline in 162 normal subjects and 120 hypertensives. Of these, 13 had primary aldosteronism (ALDO), 19 high renin (HRH), 30 low renin (LRH), and 57 normal renin (NRH) essential hypertension. FENa for normals (1.42%), NRH (1.57%), and HRH (1.46%) was similar. That for LRH (2.56%) and ALDO (4.18%) was elevated compared to the other three subgroups (P less than 0.001). Although the four hour FENa during saline infusion was associated with mean atrterial blood pressure (MABP) within the entire hypertensive population (r = 0.51), when the subgroups of the hypertensive patients were considered separately no association between FENa and MABP was identified. Moreover, the MABP of subjects with HRH was greater (P less than 0.05) than in those with NRH, although the FENa of the two subgroups was similar. Patients with ALDO and LRH have a greater natriuretic response to a salt load than do other subgroups of essential hypertension or normal subjects. The exaggerated natriuresis appears to be a feature of hypertension with renin suppression. The degree of exaggerated natriuresis in not solely a function of an elevated mean arterial blood pressure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849636     DOI: 10.1161/01.cir.55.5.779

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Genetic susceptibility to salt-sensitive hypertension in a Han Chinese population: a validation study of candidate genes.

Authors:  Zheng Liu; Han Qi; Bin Liu; Kuo Liu; Jingjing Wu; Han Cao; Jie Zhang; Yuxiang Yan; Yan He; Ling Zhang
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

2.  Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake.

Authors:  Alexander W Krug; Eric Tille; Bei Sun; Luminita Pojoga; Jonathan Williams; Bindu Chamarthi; Andrew H Lichtman; Paul N Hopkins; Gail K Adler; Gordon H Williams
Journal:  Age (Dordr)       Date:  2012-10-02

Review 3.  Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.

Authors:  J H Bauer
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

4.  Urinary kallikrein excretion in essential and mineralocorticoid hypertension.

Authors:  O B Holland; J M Chud; H Braunstein
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Proceedings From the Symposium on Kidney Disease in Older People: Royal Society of Medicine, London, January 19, 2017.

Authors:  Aza Abdulla; Pandora N Wright; Louise E Ross; Hugh Gallagher; Osasuyi Iyasere; Nan Ma; Carol Bartholomew; Karen Lowton; Edwina A Brown
Journal:  Gerontol Geriatr Med       Date:  2017-12-07

6.  Identification of biomarkers, pathways and potential therapeutic agents for salt-sensitive hypertension using RNA-seq.

Authors:  Xiaoying Chao; Zhiyuan Jiang; Guoqiang Zhong; Rongjie Huang
Journal:  Front Cardiovasc Med       Date:  2022-08-10

7.  A review of nutritional factors in hypertension management.

Authors:  Ha Nguyen; Olaide A Odelola; Janani Rangaswami; Aman Amanullah
Journal:  Int J Hypertens       Date:  2013-04-10       Impact factor: 2.420

8.  Effects of environmental and genetic risk factors for salt sensitivity on blood pressure in northern China: the systemic epidemiology of salt sensitivity (EpiSS) cohort study.

Authors:  Han Qi; Bin Liu; Chunyue Guo; Zheng Liu; Han Cao; Kuo Liu; Weiping Sun; Ling Zhang
Journal:  BMJ Open       Date:  2018-12-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.